Related Experiment Video
Updated: May 12, 2026

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
Ligand binding and aggregation of pathogenic SOD1
Gareth S A Wright1, Svetlana V Antonyuk, Neil M Kershaw
1Molecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, UK.
Mutations in copper-zinc superoxide dismutase-1 (SOD1) cause ALS. This study reveals that SOD1 stabilizers interact with an aggregate core, not the dimer interface, highlighting the need for structural insights in drug development.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Mutations in copper-zinc superoxide dismutase-1 (SOD1) are linked to amyotrophic lateral sclerosis (ALS).
- SOD1 mutations destabilize the protein, leading to aggregation, with the monomeric form potentially acting as an intermediate.
- Stabilizing the SOD1 dimer and preventing aggregation are pursued as therapeutic strategies for ALS.
Purpose of the Study:
- To investigate the structural perturbations of monomeric copper-apo, zinc-holo SOD1.
- To identify the specific binding sites of potential SOD1 stabilizers, Isoproterenol and 5-fluorouridine.
- To assess the implications of binding site identification for developing targeted therapeutics.
Main Methods:
- Characterization of monomeric copper-apo, zinc-holo SOD1 structure and aggregation propensity.
- Analysis of protein-ligand interactions between SOD1 and Isoproterenol/5-fluorouridine.
- Structural identification of ligand binding sites within SOD1.
Main Results:
- Monomeric copper-apo, zinc-holo SOD1 exhibits structural perturbations and aggregates without restoring monomer-dimer equilibrium.
- Isoproterenol and 5-fluorouridine bind to SOD1 at a region within the core of fibrillar aggregates (β-barrel loop II-strand 3).
- Ligand binding does not occur at the previously proposed dimer interface site.
Conclusions:
- Direct structural evidence reveals that SOD1 stabilizers bind to an aggregate-related site, not the dimer interface.
- This finding underscores the critical importance of direct structural studies for designing effective protein-targeted ALS therapeutics.
- Understanding the precise interaction sites is crucial for optimizing drug design and efficacy.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Ligand Binding and Linkage
Ligand Binding and Linkage
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Formation of Lipopolysaccharides

